These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2801671)

  • 21. [The stomach and bone metabolism].
    Palicka V
    Vnitr Lek; 2003 Mar; 49(3):166-7. PubMed ID: 12728585
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vitamin status and bone mineral density at patients with diseases of gastroenteric tract].
    Svetikova AA; Kodentsova VM; Vrzhesinskaia OA; Pereverzeva OG; Shakhovskaia AK; Kaganov BS
    Vopr Pitan; 2008; 77(2):32-5. PubMed ID: 18505096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insufficiency fractures of bilateral distal tibias associated with chronic liver disease.
    Tsuchie H; Miyakoshi N; Hongo M; Kasukawa Y; Ando S; Shimada Y
    J Orthop Sci; 2010 Sep; 15(5):678-81. PubMed ID: 20953931
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone disorders in chronic liver disease.
    Collier J
    Hepatology; 2007 Oct; 46(4):1271-8. PubMed ID: 17886334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry.
    Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
    Hepatology; 2002 Oct; 36(4 Pt 1):895-903. PubMed ID: 12297836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efferent loop small intestinal vitamin D receptor concentration and bone mineral density after Billroth II (Polya) gastrectomy in humans.
    Pazianas M; Zaidi M; Subhani JM; Finch PJ; Ang L; Maxwell JD
    Calcif Tissue Int; 2003 Apr; 72(4):485-90. PubMed ID: 12574872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D and metabolic bone disease: a clinicopathologic overview.
    Felsenfeld A; Llach F
    Pathol Annu; 1982; 17 (Pt 1)():383-410. PubMed ID: 6750537
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
    Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
    Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progression of hepatic osteodystrophy: pathogenesis, diagnosis and treatment].
    Han H; Wang B; Wang B
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):75-7. PubMed ID: 24754093
    [No Abstract]   [Full Text] [Related]  

  • 30. Mayo Clinic office visit. Learning more about osteopenia.
    Hurley D
    Mayo Clin Womens Healthsource; 2005 Apr; 9(4):S1-2. PubMed ID: 15891675
    [No Abstract]   [Full Text] [Related]  

  • 31. [Osteopathy and gastroenterology].
    Hofstetter JR
    Rev Med Suisse Romande; 1982 Jun; 102(6):611-3. PubMed ID: 7134719
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vitamin D deficiency in children with chronic diseases evaluated because of osteopenia].
    Reyes ML; Hernández MI; Palisson F; Talesnik E
    Rev Med Chil; 2002 Jun; 130(6):645-50. PubMed ID: 12194687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
    Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D metabolism and metabolic bone disease.
    Gaut ZN
    Curr Concepts Nutr; 1983; 12():29-47. PubMed ID: 6342973
    [No Abstract]   [Full Text] [Related]  

  • 35. Measurements of bone mineral density. Mineral density in metabolic bone disease.
    Fischer M; Raue F
    Q J Nucl Med; 1999 Sep; 43(3):233-40. PubMed ID: 10568139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of metabolic bone disease in patients on peritoneal dialysis.
    Armstrong A; Cunningham J
    Kidney Int Suppl; 1994 Dec; 48():S51-7. PubMed ID: 7700042
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
    Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alcohol, liver, and bone involvement. Hepatic osteodystrophy].
    Pumarino H
    Rev Med Chil; 1996 Aug; 124(8 Suppl):92-6. PubMed ID: 9197013
    [No Abstract]   [Full Text] [Related]  

  • 40. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.